WithdrawnPhase 4NCT01927406
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Studying Congenital glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stanford University
- Principal Investigator
- Andrea L. Kossler, M.D.Stanford University
- Intervention
- Prostaglandin Analog(drug)
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- Stanford Hospital and Clinics, Stanford, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01927406 on ClinicalTrials.govOther trials for Congenital glaucoma
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT06969586The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal DystrophyUniversity Hospital Dubrava
- ACTIVE NOT RECRUITINGNANCT06837610Inverted T Trabeculectomy Primary Congenital GlaucomaBenha University
- RECRUITINGNANCT04129021High Resolution, High-speed Multimodal Ophthalmic ImagingCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- RECRUITINGNCT02014389Evaluation of Objective Perimetry Using Chromatic Multifocal PupillometerSheba Medical Center